About Sofinnova Capital XI
Paris-based eleventh flagship vehicle, bringing AUM to ~€1.5B. One of Europe's largest life sciences funds, investing in 50-60 early-stage biotech and medtech startups.
Investor Signals Profile
active
Sweet Spot
Clinical-stage biotech founders with human trial data
Unlock Investor Signals
$29/month for full signal access. Cancel anytime.